Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to protect Kids' immune systems during chemo

NCT ID NCT04570423

First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 24 times

Summary

This study tests a drug called eflapegrastim in children with solid tumors or lymphoma who are receiving chemotherapy. The goal is to see if it safely helps their white blood cell counts recover faster, reducing the risk of severe infections. About 40 children will take part, and researchers will monitor side effects and how well the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Carolinas Medical Center/ Levine Children's Hospital

    TERMINATED

    Charlotte, North Carolina, 28203, United States

  • Levine Children's Health

    TERMINATED

    Charlotte, North Carolina, 28203, United States

  • New York Medical College

    TERMINATED

    Valhalla, New York, 10595, United States

  • UT MD Anderson Cancer Center

    TERMINATED

    Houston, Texas, 77030, United States

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

Conditions

Explore the condition pages connected to this study.